Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme

British Journal of Cancer

Volumn 104, Issue 12, 2011, Pages 1810-1815

  Guilfoyle, M R ^a   Weerakkody, R A ^a   Oswal, A ^a   Oberg, I ^a   Jeffery, C ^a   Haynes, K ^a   Kullar, P J ^a   Greenberg, D ^b   Jefferies, S J ^c   Harris, F ^c   Price, S J ^a   Thomson, S ^d   Watts, C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Eastern Cancer Registration and Information Centre   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

chemotherapy; glioblastoma; management; NICE guidance; radiotherapy; surgery

Indexed keywords

TEMOZOLOMIDE;

ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CLINICAL PROTOCOL; COST OF ILLNESS; DATA BASE; DIAGNOSTIC IMAGING; ELECTIVE SURGERY; EMERGENCY HEALTH SERVICE; GLIOBLASTOMA; HEALTH SERVICE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; TREATMENT OUTCOME;

EID: 79958171009     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.153     Document Type: Article

References (22)

1. Albright AL, Sposto R, Holmes E, Zeltzer PM, Finlay JL, Wisoff JH, Berger MS, Packer RJ, Pollack IF (2000) Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery 47(4): 879-887 (Pubitemid 32103664)
2. Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40(16): 2494-2501 (Pubitemid 39424966)
3. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP (2005) Years of life lost (YLL) from cancer is an important measure of population burden and should be considered when allocating research funds. Br J Cancer 92(2): 241-245 (Pubitemid 40343136)
4. Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82(1): 81-83
5. Curran Jr WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85(9): 704-710 (Pubitemid 23133591)
6. de Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ (2004) Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63(3): 535-537 (Pubitemid 39031388)
7. Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, Watts C (2009) An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 176(2): 192-199
8. Gooiker GA, van Gijn W, Post PN, van de Velde CJ, Tollenaar RA, Wouters MW (2010) A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider? Eur J Surg Oncol 36(Suppl 1): S27-S35
9. Kesari S, Stiles CD (2006) The bad seed: PDGF receptors link adult neural progenitors to glioma stem cells. Neuron 51(2): 151-153 (Pubitemid 44041869)
10. Latif AZ, Signorini DF, Whittle IR (1998) Treatment by a specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma. Br J Neurosurg 12(1): 29-32 (Pubitemid 28073627)
11. NICE (2006) Service guidance for improving outcomes for people with brain and other central nervous system tumours. Retrieved 1 January 2011, http://www.nice.org.uk/nicemedia/pdf/CSG-brain-manual.pdf
12. NICE (2007) TA121 glioma (newly diagnosed and high grade) - carmustine implants and temozolomide: guidance. Retrieved 1 January 2011, http://www.nice.org.uk/nicemedia/pdf/TA121guidance.pdf
13. Pichlmeier U, Bink A, Schackert G, Stummer W, ALA Glioma Study Group (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6): 1025-1034
14. Rachet B, Mitry E, Quinn MJ, Cooper N, Coleman MP (2008) Survival from brain tumours in England and Wales up to 2001. Br J Cancer 99(S1): S98-S101
15. Stewart L (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359(9311): 1011-1018 (Pubitemid 34286538)
16. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5): 392-401
17. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5): 459-466
18. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10): 987-996 (Pubitemid 40349501)
19. van Gijn W, Gooiker GA, Wouters MW, Post PN, Tollenaar RA, van de Velde CJ (2010) Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol 36(Suppl 1): S55-S63
20. Walker MD, Alexander Jr E, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49(3): 333-343 (Pubitemid 9013313)
21. Walker MD, Green SB, Byar DP, Alexander Jr E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, Owens G, Ransohoff 2nd J, Robertson JT, Shapiro WR, Smith Jr KR, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23): 1323-1329 (Pubitemid 11194457)
22. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5(2): 79-88 (Pubitemid 36422560)